Molecular modelling of the FERM, SH2 and kinase-like domains of Jaks:
Supplemental table 1: Four Janus kinases transmit the signals of many cytokines. 1 The classification of cytokines is based on their receptor complexes. 2 Of the three Jaks activated by IL-6-type cytokines, only Jak1 seems to be crucial. 3 The murine OSM receptor, unlike the human one, strongly binds Jak2 [12] . 4 Two receptor complexes with different tissue distribution mediate signalling of Predictions were made based on the composition of the respective receptor complexes if the involvement of Jaks has not yet been fully elucidated, (e. g. for IL-26). Abbreviations: CLC, cardiotrophin-like cytokine; CNTF, ciliary neurotrophic factor; CT, cardiotrophin; GCSF, granulocyte colony stimulating factor; Epo, Erythropoietin, GH, growth hormone; IFN, interferon; IL, interleukin; LIF, leukemia inhibitory factor; NP, neuropoietin; OSM, oncostatin M; Tpo, trombopoietin; TSLP, thymic stromal lymphopoietin Type II receptor cytokines Extended IL2 family Common β chain users Extended IL6 family Cytokine 1 Jak1 Jak2 Jak3 Tyk2
Cytokines signaling through homodimeric receptors
X Prolactin X IL-2 X X IL-4 4 X X IL-7 X X IL-9 X X IL-15 X X IL-21 X X TSLP X X IL-13, IL-4 4 X X X IFNα/β X X IFNγ X X IL-10 X X IL-19 X X IL-20 X X IL-22 X X IL-24 X X IL-26 5 X X IL-28A/B X X IL-29 X X Supplemental figure 1: Non-conserved residues around the ATP-and substrate binding sites. A: Non-conserved residues in the kinase domains of Jak1, Jak2 and Jak3 that may be exploited for the design of more specific Jak inhibitors (PDB entry codes for the structures: 3EYG, 2B7A and 1yvj). An overlay of Jak1, Jak2 and Jak3 kinase domain structures is shown and the three kinase domains are shown separately. The Jak1 residues are highlighted in yellow, the Jak2 residues in green and the Jak3 residues in turquoise. The JSI region is highlighted by a red frame. The kinase inhibitors are depicted as stick models. Jak1: MI1; CP-690550;
-F]-isoquinoline-7-one, Jak3: 4ST; AFN941; 1,2,3,4-tetrahydrogenstaurosporine. B: Table with the selected non-conserved residues in the kinase domains of Jak1, Jak2, Jak3 and Tyk2.
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Jak1/Jak2/Jak3 overlay Ptk2B(415): ..GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHK.....................GEKINVAVKTCKKDCTLDNKEKFMSEAV  SRC (258): LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW.........................NGTTRVAIKTLKP..GTMSPEAFLQEAQ  FGFR (464): PEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKP.................NRVTKVAVKMLKSDATEKDLSDLISEME  IR (1047): FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKG............... Residues which are conserved in all the Jaks and in three of four reference sequences are indicated in red. Residues that are rather conserved in only the Janus kinases are indicated in blue. Residues for which mutations have been identified in patients with haematologic diseases are highlighted in yellow (Jak1), green (Jak2), turquoise (Jak3) and grey (Tyk2) and the corresponding mutations are indicated below the sequences. Due to the large number of exon 12, exon 14 and exon 16 mutations identified in Jak2, these mutations are not specifically named (please refer to Table 1 in the main document). Mutation which were only found in combination with another mutation are followed by a "+" sign. Regions which are subject to deletions and/or insertions are underlined. An initial alignment was performed using the BLAST program and modifications were subsequently introduced to meet the structural requirements derived from the known reference structures. Accession numbers for the used Jak sequences used are: NP_002218 (hJak1), NP_004963 (hJak2), AAC50950 (hJak3) and P29597 (hTyk2). A: reference sequences and structures for the FERM domain are from focal adhesion kinase (FAK; PDB code: 2AL6), radixin (RAD, PDB code: 1GC7), moesin (MOE, PDB code: 1EF1 ) and merlin (MER; PDB code: 1H4R). The FERM subdomains F1 to F3 are indicated above the sequences. B: Reference sequences and structures for the SH2 domains are from phospholipase Cγ (PLC, PDB code: 2PLD), the C-terminal SH2 domain of the p85 alpha subunit of phosphoinositide 3-kinase (P85aC; PDB code: 1BFJ), the C-terminal SH2 domain of SHP2 (SHP2C; PDB code: 2SHP) and Bcr-Abl (BAbl, PDB code: 2ABL). Secondary structure elements for SHP2C are given. Reference sequences and structures for the pseudokinase domain were from the following kinases: protein tyrosine kinase 2 beta (Ptk2B; PDB code: 3CC6), c-Src (SRC, PDB code: 1FMK), fibroblast growth factor receptor (FGFR; PDB code: 1FGK) and insulin receptor (IR; PDB code: 1IR3). The 30 amino acid sequence from the epidermal growth factor receptor (EGFR; PBD code: 1m17) and the corresponding structure served as template for the modelling of the N-terminal parts of the Jak pseudokinase domains (e.g. exon 12 region in Jak2). Secondary structure elements are given above the sequence. C: Reference sequences and structures were the same as used for the pseudokinase sequence alignment. Secondary structure elements for the Jak2 kinase domain are indicated above the sequence (α: alpha helix; β: beta strand; 3: 3/10 helix). ---------------------------------------------hJak1(948) : GGNGIKLIMEFLPSGSLKEYLPKNK...............NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI  hJak2(921) : GRRNLKLIMEYLPYGSLRDYLQKHK...............ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI  hJak3(894) : GRPELRLVMEYLPSGCLRDFLQRHR...............ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKI  hTyk2(970) : GEKSLQLVMEYVPLGSLRDYLPR.................HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKI  Ptk2B : (see table 1) . Residues for which activating point mutations were reported in patients are represented as yellow (Jak1), green (Jak2) or turquoise (Jak3) stick models with spheres indicating the Van-der-Waals radii of atoms. Regions carrying insertions and/or deletions are indicated by a coloured backbone without stick models (black frames). The proposed Jak2 structural mutation hotspots I and II are highlighted in red. (biochemically validated and non-validated; table 1) . Residues for which point mutations were reported in patients are represented as yellow (Jak1), green (Jak2) or turquoise (Jak3) stick models with spheres indicating the Van-der-Waals radii of atoms. Regions carrying insertions (ins) and/or deletions (del) are indicated by a coloured backbone without stick models. Please refer to table 1 for the detailed denomination of the different insertions and/or deletions in Jak2 exons 12 and 16. The proposed structural mutation hotspots I and II are highlighted in red. 3EYG, 2B7A and 1yvj, respectively) . An overlay of Jak1, Jak2 and Jak3 kinase domain structures is shown and the three kinase domains are shows separately. Residues for which point mutations were reported in patients are represented as yellow (Jak1) or green (Jak2) stick models with spheres indicating the Van-der-Waals radii of atoms. The activation loops of the three Jaks are highlighted in the overlay representation by a dashed box. The phosphotyrosine residues within the activation loop of the kinases are represented as dotted spheres. activation loops
All reported mutations
